News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon ‘Next-Gen’ Colorectal Cancer Screening Test

DGAP-News: Epigenomics AG / Key word(s): Personnel24.01.2022 / 07:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon “Next-Gen” Colorectal Cancer Screening Test Greg Hamilton retained as CEO through 2025 Appointment underscores Epigenomics’ commitment to the […]

Read more

​​​​​​​Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer

DGAP-News: Epigenomics AG / Key word(s): Personnel14.12.2021 / 07:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer Jens Ravens is an internationally experienced leader with in-depth experience in Controlling, Finance, M&A, IT, Legal, and Human Resources New Chief Financial Officer […]

Read more

​​​​​​​Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer

DGAP-News: Epigenomics AG / Key word(s): Personnel18.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Supervisory Board of Epigenomics AG Appoints Dr. Andrew Lukowiak as President and Chief Scientific Officer Dr. Andrew Lukowiak is a proven senior executive with deep technology and development expertise Appointment underscores Epigenomics’ commitment to the […]

Read more

Epigenomics AG publishes financial results for the first nine months 2021

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results10.11.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for the first nine months 2021 Berlin (Germany) and San Diego, CA (U.S.A.), November 10, 2021 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the “Company”) today […]

Read more

Epigenomics AG: EVP of Finance Albert Weber leaves the Company

DGAP-News: Epigenomics AG / Key word(s): Personnel07.10.2021 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG: EVP of Finance Albert Weber leaves the Company Berlin (Germany) and San Diego, CA (U.S.A.), October 7, 2021 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that Executive Vice […]

Read more

Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million

DGAP-News: Epigenomics AG / Key word(s): Bond/Issue of Debt13.09.2021 / 13:24 The issuer is solely responsible for the content of this announcement. NOT TO BE PUBLISHED, DISSEMINATED OR PASSED ON TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA AND SOUTH AFRICA Press Release Epigenomics AG places maximum number of mandatory convertible bonds […]

Read more